Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;7(8):e2162.
doi: 10.1002/cnr2.2162.

Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis

[Article in Spanish]
Kaitlyn C Dykes  1   2 , Jiling Chou  3 , Allison O Taylor  4 , Albert C Shu  1 , Sarah E Mudra  1 , Xiaoyang Ma  3 , Jaeil Ahn  3 , Catherine E Lai  5   6
Affiliations

Survival Outcomes in Older Adult Acute Lymphoblastic Leukemia Patients Analyzed by Facility Volume and Type: A National Cancer Database Analysis

[Article in Spanish]
Kaitlyn C Dykes et al. Cancer Rep (Hoboken). 2024 Aug.

Abstract

Bakground: It is important to understand the outcomes of adult acute lymphoblastic leukemia (ALL) patients at different facilities as treatment paradigms change.

Aims: Our primary objective was to determine adult ALL overall survival (OS) by facility volume and type. Secondary objectives included identifying sociodemographic factors that may have impacted outcomes and analyzing treatment patterns by facility volume and type.

Methods: This was a retrospective analysis of the National Cancer Database (NCDB) that included patients ≥40 years diagnosed with ALL between 2004 and 2016.

Results: A total of 14 593 patients were included in this study. Univariate OS was greatest at low volume (LV) and community programs (CPs) and the least at high volume (HV) and academic programs (AP). This difference was lost after multivariable Cox proportional hazards model analysis, which found no difference in survival by facility volume or type, however, survival was significantly influenced by age, race, Hispanic ethnicity, insurance, and residence location (p < 0.05). Patients treated at HV and APs compared to LV and CP received more anti-neoplastic directed therapy.

Conclusion: Our results suggest treatment facility volume and type do not impact older adult ALL patient (≥40 years) survival, however confounding sociodemographic differences do impact survival outcomes, despite more aggressive and novel treatment approaches provided at HV and APs.

Keywords: epidemiology; hematalogical cancer; leukemia; survival.

PubMed Disclaimer

Conflict of interest statement

The authors have no relevant conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Kaplan–Meier (KM) overall survival (OS) curve including patients ≥40 years, by facility volume and type. OS was censored by death or last follow‐up. Stratified analysis of patients ≥40 years found OS was longest at LV and CP (71.1 months) and the shortest at HV and AP (59.6 months), p < 0.001. A total of 3429 observations were excluded from the analyses due to missing data.
FIGURE 2
FIGURE 2
Kaplan–Meier (KM) overall survival (OS) curve including patients ≥40 years who received no treatment other than palliative care (no immunotherapy, chemotherapy, radiation, and transplant) by facility volume and type. OS was censored by death or last follow‐up.
FIGURE 3
FIGURE 3
Hazard ratio (HR) and odds ratio (OR) by initial treatment received (immunotherapy, chemotherapy, radiation, transplant, and palliative) by facility volume and type for patients ≥40.
See this image and copyright information in PMC

References

    1. Pui C. H., Relling M. V., and Downing J. R., “Acute Lymphoblastic Leukemia,” New England Journal of Medicine 350, no. 15 (2004): 1535–1548. - PubMed
    1. Pui C. H., Robison L. L., and Look A. T., “Acute Lymphoblastic Leukaemia,” Lancet 371, no. 9617 (2008): 1030–1043. - PubMed
    1. Redaelli A., Laskin B. L., Stephens J. M., Botteman M. F., and Pashos C. L., “A Systematic Literature Review of the Clinical and Epidemiological Burden of Acute Lymphoblastic Leukaemia (ALL),” European Journal of Cancer Care 14, no. 1 (2005): 53–62. - PubMed
    1. Heikamp E. B. and Pui C. H., “Next‐Generation Evaluation and Treatment of Pediatric Acute Lymphoblastic Leukemia,” Journal of Pediatrics 203 (2018): 14–24. - PMC - PubMed
    1. Larson R., “Acute Lymphoblastic Leukemia,” in Williams Hematology, 10th ed., eds. Kaushansky K., Prchal J. T., Burns L. J., Lichtman M. A., Levi M., and Linch D. C. (McGraw Hill, 2021), 1593–1610. bookid=2962&sectionid=252143520.

Publication types

LinkOut - more resources